Below you will find the latest press releases from Evolva. You are also welcome to dive into the archive and browse our press releases from there as well:
Latest Press Releases
Reinach, Switzerland, 17 December 2014 – Evolva Holding SA (“Evolva”, SIX: EVE) today announced that Emergent BioSolutions Inc. (“Emergent”, NYSE: EBS) has acquired Evolva’s anti-bacterial programme, the EV-035 series.
Reinach, Switzerland, 16 December 2014 – Evolva Holding SA (SIX: EVE), today announces the completion of the acquisition of Allylix, Inc., after which Allylix will be a wholly-owned subsidiary of Evolva. This acquisition was announced on 18 November 2014.
Reinach, Switzerland, 11 December 2014 – Evolva Holding SA (SIX: EVE) today announces the signing of a binding term sheet for an exclusive collaboration with Takasago International Corporation, Japan.
Expands product portfolio and strengthens stevia franchise
Cargill to increase stake in Evolva
First products on market.
Evolva and Cargill are pioneering the production of great tasting, next-generation sweeteners via fermentation
Reinach, Switzerland, 14 August 2014 – Evolva Holding SA (SIX: EVE) today announces it has entered into a contract (HDTRA1-14-C-0122) with the US Defense Threat Reduction Agency (DTRA)
Reinach, Switzerland, 4 August 2014 – Evolva Holding SA (SIX: EVE) today announces the acquisition of Cambridge, UK based Prosarix Ltd., a leading in silico (computational) modelling company.
Focus on Biosynthesis of High Value Indigenous Malaysian Natural Products
Reinach, Switzerland, 28 May 2014 – Evolva Holding SA (SIX: EVE) today announces the start of commercial production of its resveratrol ingredient.
- 1 of 2
- next ›